Boost For Brain Cancer As Tocagen Enters EMA’s PRIME

 
• By Neena Brizmohun
  
Tumour
Tocagen's drug for glioma is now on the PRIME scheme • Source: Shutterstock

More from Market Access

More from Pink Sheet